CEFPROZIL TABLETS DIN 02332043
Status: Cancelled Pre Market
Holder: RANBAXY PHARMACEUTICALS CANADA INC.
Molecule: CEFPROZIL (CEFPROZIL MONOHYDRATE)
Health Canada record
| Active ingredient(s) | CEFPROZIL (CEFPROZIL MONOHYDRATE) 500 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DC10 CEFPROZIL |
| Original market date | |
| Current status date | 10-Jul-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ranbaxy Pharmaceuticals Canada Inc. (a SUN PHARMA Company) — licence 101281, not currently licensed, last inspection rating C (2022-02-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFPROZIL (CEFPROZIL MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02347261 | AURO-CEFPROZIL | AURO PHARMA INC | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 125 MG | Marketed |
| 02347288 | AURO-CEFPROZIL | AURO PHARMA INC | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Marketed |
| 02293536 | SPC-CEFPROZIL | SUN PHARMA CANADA INC | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 500 MG | Marketed |
| 02329204 | SPC-CEFPROZIL | SUN PHARMA CANADA INC | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 125 MG | Marketed |
| 02293579 | SPC-CEFPROZIL | SUN PHARMA CANADA INC | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Marketed |
| 02293528 | SPC-CEFPROZIL | SUN PHARMA CANADA INC | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Marketed |
| 02292998 | APO-CEFPROZIL | APOTEX INC | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Dormant |
| 02293005 | APO-CEFPROZIL | APOTEX INC | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 500 MG | Dormant |
| 02362872 | AVA-CEFPROZIL | AVANSTRA INC | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Cancelled Post Market |
| 02362864 | AVA-CEFPROZIL | AVANSTRA INC | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 125 MG | Cancelled Post Market |
| 02324180 | CEFPROZIL | PRO DOC LIMITEE | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 500 MG | Cancelled Post Market |
| 02332027 | CEFPROZIL POWDER FOR ORAL SUSPENSION | RANBAXY PHARMACEUTICALS CANADA INC. | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Cancelled Pre Market |
| 02332035 | CEFPROZIL TABLETS | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Cancelled Pre Market |
| 02317303 | MINT-CEFPROZIL | MINT PHARMACEUTICALS INC | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Cancelled Post Market |
| 02317311 | MINT-CEFPROZIL | MINT PHARMACEUTICALS INC | Tablet | CEFPROZIL (CEFPROZIL MONOHYDRATE) 500 MG | Cancelled Post Market |
| 02303426 | SANDOZ CEFPROZIL | SANDOZ CANADA INCORPORATED | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 125 MG | Cancelled Post Market |
| 02303434 | SANDOZ CEFPROZIL | SANDOZ CANADA INCORPORATED | Powder For Suspension | CEFPROZIL (CEFPROZIL MONOHYDRATE) 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10523 | 2009-08-20 | Abbreviated New Drug Submission (ANDS) | Additional product name |